Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net income	$ 362,451	$ 342,989	$ 234,579
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	224,010	169,231	132,328
Deferred income taxes	16,466	32,074	31,040
Loss (gain) on disposition of assets	4,557	(190)	1,137
Share-based compensation	44,461	34,693	28,588
Excess tax benefit from share-based compensation	(4,473)	(4,031)	(3,622)
Non-cash interest expense	2,799	2,780	2,180
Non-cash (reduction) increase in contingent consideration	(6,717)	1,577
(Increase) decrease in:
Receivables, net	(145,728)	(138,257)	(114,354)
Inventories	(15,229)	(89,184)	(67,400)
Other current assets	38,945	(100,438)	10,391
Pre-production and development costs	(64,008)	(24,873)	7,821
(Decrease) increase in:
Accounts payable	(44,657)	273,627	147,994
Accrued warranties	15,564	32,971	21,061
Accrued other liabilities	28,125	47,851	127,950
Income taxes payable	5,482	46,131	8,926
Net change in derivative assets and liabilities	(5,560)	(55,246)	18,121
Other operating activities	(9,960)	(19,102)	5,400
Net cash provided by operating activities	446,528	552,603	592,140
Cash flows from investing activities:
Acquisitions, net of cash received	(227,231)	(556,475)	(422,953)
Capital expenditures	(198,455)	(192,498)	(157,141)
Maturities of short-term investments			10,008
Proceeds from asset dispositions	119	4,552
(Purchase) sale of investments for irrevocable trust	(309)	5,005	(42,400)
Other items, net		950	434
Net cash used in investing activities	(425,876)	(738,466)	(612,052)
Cash flows from financing activities:
Decrease in short-term borrowings	(994)	(2,569)	(1,162)
Borrowings of long-term debt	275,000	1,068,892	300,000
Repayments of long-term debt	(38,550)	(552,298)	(30,000)
Debt issuance costs		(9,668)
Cash dividends to shareholders	(100,651)	(92,600)	(83,053)
Repurchase of common stock	(140,031)		(90,779)
Exercise of stock options	6,937	27,676	48,626
Repurchases related to share-based compensation arrangements	(11,933)	(22,318)	(12,316)
Excess tax benefit from share-based compensation	4,473	4,031	3,622
Payment of contingent consideration	(27,138)	(327)
Repayments of acquiree debt	(2,572)	(121,198)
Purchase of non-controlling interest	(17,664)
Other items, net	(4,512)	5,565	1,666
Net cash (used in) provided by financing activities	(57,635)	305,186	136,604
Effect of exchange rate changes on cash	(10,230)	(51,122)	10,362
Net (decrease) increase in cash and cash equivalents	(47,213)	68,201	127,054
Cash and cash equivalents at beginning of period	649,513	581,312	454,258
Cash and cash equivalents at end of period	602,300	649,513	581,312
Non-cash investing activities:
Accrued and contingent acquisition-related liabilities	$ 103,086	280,346	$ 13,384
Common stock issued in connection with acquisitions		$ 316,035